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Intermediate products of the metabolism of glucose, fat and
amino-acid are important in the evaluation of such metabolic
disorders as diabetes mellitus, liver disease and metabolic acidosis.
In the present study, methodsfor the measurement of intermediate
metabolites (lactate, pyruvate, alanine, -hydroxybutyrate and
glycerol) have been adapted to a fast centrifugal analyzer: the
COBAS FARA. Correlation coeffcients rangedfrom 0"90 to 0"99,
compared to established manual spectrophotometric methods.
Within-run coeffcients of variation (CVs) ranged between 2"9 and
8"80//o at low levels, between 1"5 and 5"70//0 at medium levels and
between 1"2 and 5"6o//0 at high levels. Between-run CVs were between
4"0 and 15"0% at low levels, between 1"7 and 7"0% at medium
levels and between 1"3 and 2"70//0 at high levels. Thesejquorimetric
assaysfor the determination ofintermediate metabolites on COBAS
FARA (Roche) have a good sensitivity andprecision, are less costly
than manual methods and can be used on a routine basis.
Introduction
The measurement of intermediate metabolism products
was used in the past to understand such metabolic
disorders as diabetes mellitus, liver disease and metabolic
acidosis [1-5]. They are now measured to evaluate early
metabolic alterations in certain classes of patients, for
example obese patients and relatives of diabetic subjects
who are at risk for developing metabolic disorders.
Enzymatic assays for intermediate metabolites were
devised in the 1950s [6], and manual methods for the
determination of intermediate metabolites (lactate, pyru-
vate, alanine, fl-hydroxybutyrate and glycerol) were
rapidly developed for the study of physiological and
pathological states [7-1 1], however, these methods are
laborious and have little sensitivity. They are also expen-
sive, as they use relatively large quantities ofenzymes with
little substrate to enable the reaction to proceed rapidly
to equilibrium. In order to analyse large numbers of
samples rapidly in small volumes of blood or plasma,
automated photometric [12] or fluorimetric techniques
[13 and 14] have been developed utilizing either
continuous flow methods [15] or centrifugal analysers
with a fluorimetric attachment [16-18]. These methods
are more precise and sensitive and use very little sample,
thus making metabolic studies possible in children and
neonates. The present study started from the need to use
fluorimetric methods with assays particularly suited to
routine work. The measurement of lactate, fl-hydroxy-
butyrate, alanine, pyruvate and glycerol was developed
on a fast centrifugal analyser (COBAS FARA).
Materials and methods
Patients
Fifty subjects were subdivided into three groups: normal;
impaired glucose tolerant; and diabetic patients attending
a diabetic clinic. Each patient had a random blood sample
for the determination of intermediate metabolites. They
were chosen because they had a wide concentration range
of all metabolites. Blood samples were processed simul-
taneously using the COBAS FARA methods and manual
methods described in the literature [7-11].
Sample preparation
Lactate, fl-hydroxybutyrate, alanine, pyruvate and
glycerol are unstable in whole blood and an immediate
and correct processing of the sample is necessary at the
time of venepuncture [15]. Plastic tubes containing 3 ml
of5 (0"5 mol/1)perchloric acid (PCA), previously cooled
to 0C, were weighed; 1-1.5 ml of blood was added
immediately after sampling and the tube was weighed
again, thus giving an accurate measurement ofthe amount
of blood used. In a few pathological cases, whether the
levels of metabolites were over the highest calibrator
points, dilutions were made adding adequate: amounts of
5% PCA. All these changes were taken into account in
the final calculation of the data.
Comparison of methods
The methods of measurement for lactate, pyruvate,
alanine, fl-hydroxybutyrate and glycerol were adapted
for use on the COBAS FARA II (Roche, Basle, Switzer-
land) with a fluorimetric attachment by making a number
of modifications in the composition of buffers, and
coenzyrne/enzyme reagents used in previous methods [ 16]
and modifying the reaction modes available on the
analyser to take the improved calculation programs into
account.
In order to compare the methods under study, manual
spectrophotometric assays [7-11] were performed with a
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550 SE UV/VIS spectrophotometer (Perkin-Elmer). In
this case,, samples were precipitated with PCA but the
dilution ratio was 1"1.
Reagents
NAD (free acid, grad I 100, cat. 127965), NADH
(disodium salt, grad I 100, cat. 837075), lactat-
dehydrogenase 100 mg (10 ml) cat. 107085, -hydroxy-
butyrate-dehydrogenase 25 mg (5 ml) cat. 127841, L-
alanin-dehydrogenase (150 U) cat. 102636, glycero-
kinase 5 mg (1 ml) cat. 127795, glycerin-3-phosphat-
dehydrogenase 10mg (1 ml) cat. 127752, ATP cat.
519979, fl-hydroxybutyrate (monosodium salt), pyruvate
(monosodium salt), and L-alanine (crystallized) were all
supplied by Boehringer Mannheim GmbH, Germany.
Lactic acid (lithium salt) and glycerol were supplied by
the Sigma Chemical Co., PO Box 14508, St. Louis, MO
63178, USA.
Assay procedures
Lactate. Buffer: 0"5 mol/1 glycine, 1"6 mol/1 hydrazine
hydrochloride, adjusted to pH 9"6 with 10 mol/1 sodium
hydroxide (reagent solution). Enzyme reagent: 50mg
NAD and 500 gl lactate dehydrogenase in 3"5 ml 0" mol/1
phosphate buffer, pH 7"4 (starter solution). Calibrators:
0, 625, 125, 250, 500, 750, 1000 gmol/1. Dilutions of the
calibrator curve were made using PCA 3.
The PM voltage was set using 1200 gmol/1 calibrator.
The program was set by introducing the following
variables: calibration mode: logit/log 4; sample volume:
5"0 gl; reagent solution: 270 gl; starter solution: 20 l.tl;
incubation time: 310 s; MI: 300 s; number of readings: 10;
interval between readings: 30 s; calculation step: endpoint
(first M1, last 10).
-hydroxybutyrate. Buffer: 0"1 mol/1 TRIS, mol/1 hydra-
zine hydrate, 2"7 mol/1 EDTA (disodium salt) adjusted to
pH 8"5 with 10 mol/1 hydrochloric acid. Enzyme reagent:
10 mg NAD and 350 gl fl-hydroxybutyrate dehydrogen-
ase in 5"0 ml 0"1 mol/1 Phosphate buffer, pH 7"4. The
reagent solution is prepared by adding 0"7 ml of this
solution to 8"8 ml of the buffer. Calibrators: 12.5, 25, 50,
75, 100, 200, 300 gmol/1. Dilutions of the calibrator curve
were made using PCA 3.
The PM voltage was set using top calibrator (300 gmol/1).
The program was set by introducing the following
variables: calibration mode: linear regression; sample
volume: 20 gl; reagent volume: 270 gl; number ofreadings
20; interval between readings: 30s; calculation step:
endpoint (first 1, last 20).
Calibrators: 50, 75, 100, 150, 300 gmol/1. Dilutions of the
calibrator curve were made using PCA 3.
ThePM voltage was set using top calibrator (300 gmol/1).
The program was set by introducing the following
variables: calibration mode: linear regression; sample
volume: 10 gl; reagent volume: 270 gl; number of read-
ings: 20; interval between readings: 30 s; calculation step:
endpoint (first 1, last 20).
Pyruvate. Buffer: 0"4 mol/1 triethanolammonium chloride,
10retool/1 disodium EDTA, adjusted to pH 7"4 with
10mol/1 sodium hydroxide. Coenzyme reagent: mg
NADH in ml of 0"1 mol/1 phosphate buffer pH 7"4, the
final reagent is prepared by adding 100 gl of this solution
to 8 ml of the buffer (reagent solution).
Enzyme reagent: 25 lal lactate dehydrogenase is added to
2 ml 0" mol/1 phosphate buffer, pH 7"4 (starter solution).
Calibrators 12"5, 25, 50, 75, 100 l.tmol/1. Dilutions of the
calibrator curve were made using PCA 3.
The PM voltage was set using water as sample.
The program was set by introducing the following
variables: calibration mode: linear regression; sample
volume: 10 gl; reagent solution: 170 lal; starter solution:
10 l.tl; incubation time: 300 s; number of readings: 10;
interval between readings: 30 s; calculation step: endpoint
(first 1, last 10).
Glycerol. Buffer" 0"2 mol/1 glycine, mol/l, hydrazine
hydrate, 10mmol/1 magnesium chloride brought to
pH 9"5 with 10 mol/1 sodium hydroxide.
Enzyme reagent: 3 mg NAD, 3 mg ATP, 15 gl glycero-
kinase and 30 lal glycerol-3-phosphate dehydrogenase in
ml of the pyruvate buffer pH 7"4.
The final reagent solution is prepared by adding ml of
this reagent to 8"8 ml of the buffer.
Calibrators: 12"5, 25, 50, 75, 100 gmol/1. Dilutions of the
calibrator curve were made using PCA 3.
The PM voltage was set using 150 gmol/1 calibrator.
The program was set by introducing the following
variables: calibration mode: linear regression; sample
volume: 10gl; reagent solution: 270gl; number of
readings: 12; interval between readings: 30 s; calculation
step: endpoint (first 1, last 12).
Statisticl analysis
Data are presented as mean +_SD.
Data were processed by least-squares regression analysis.
Alanine. Buffer: 0-04 mol/1 TRIS, mol/1 hydrazine
hydrate, 1"34 mmol/1 EDTA (disodium salt)adjusted to
pH 10-0 with 10 mol/1 hydrochloric acid.
Enzyme reagent" 20 mgNAD and 100 lal alanine dehydro-
genase in 10 ml 0"1 mol/1 phosphate buffer pH 7"4. The
reagent solution is prepared by adding 0"7 ml of this
solution to 8"8 ml of the buffer.
Results
Typical calibration curves obtained for the five inter-
mediate metabolites with the COBAS FARA II are
reported in figure 1. Good repeatability of the calibration
curves was found for all the metabolites, collecting data
from 15 calibration curves over a period of three months.
CVs were always higher at the lowest points of the
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Figure 1. Calibration curves of lactate (A), -hydroxybutyrate (B), glycerol (C), alanine (D) and pyruvate (E).
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Table 1. Coefficients ofvariation CVs) ofthe calibration curves.
Lowest points Highest points
(range) (range)
Lactate 3-6-5"4% 0"6-2’4%
fl-oh-but 4"3-9"6% 0"6-1"4%
Glycerol 1"1-3"8% 1"1-3’8%
Alanine 0"5-2"9% 0"5-2"9%
Pyruvate 4"2-7"6% 1"3-2’8%
in table 2. Within- and between-run CVs were within an
acceptable range in all cases except pyruvate, suggesting
a high precision of the methods.
The methods correlated well with manual methods (see
table 3); a very small positive intercept, not significantly
different from zero, was obtained in all cases except for
-hydroxybutyrate. This is probably because manual
spectrophotometric methods are less sensitive than fluori-
metric methods at low concentrations of analytes.
calibration curves; better values were found at the highest
points of the calibration curves (table 1).
Analytical recovery was made after adding a calibrator
(low, medium or high) to three unknown samples
Average analytical recovery () (+__SD) was 100"1 (0"6)
for lactate, 98"5 (2"6) for fl-hydroxybutyrate, 95"8 (2"7)
for alanine, 101"0 (5"3)for pyruvate and 100"3 (1"0) for
glycerol.
The precision of the fluorimetric methods on the COBAS
FARA II was tested by performing within-run and
between-run CVs ofPCA samples" the results are reported
Discussion
In this study fluorimetric methods for the determination
of intermediate metabolites (lactate, pyruvate, alanine,
glycerol, //-hydroxybutyrate) have been adapted to the
COBAS FARA, a fast centrifugal analyser. In the past,
intermediate metabolites were assayed using either
manual spectrophotometric methods or fluorimetric
methods [-7-11, 16-19]. When compared to manual
methods, the methods described are quicker (5-10 min.
versus 30 min.) and cheaper (with savings of more than
100 in terms of enzyme and coenzyme costs). They are
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Table 2. Within-run and between-run CVs (%)from control samples (gmol/1).
Within run (N 30)
Low Medium High Low
Between run
Medium High
Lactate Expected value 62"5 125"0 500"0 N 44
Mean 61"4 128"7 500"3 Mean 62"7
CV 3"6 3"2 2"3 CV 6"1
fl-oh-but Expected value 25"0 75"0 100"0 N 23
Mean 23"9 74"0 98"7 Mean 24"4
CV 3’8 2" 2"0 CV 4"0
Glycerol Expected value 12"5 25"0 50"0 N 61
Mean 11"4 24"8 51"0 Mean 11"3
CV 3"8 1"5 1"2 CV 5"3
Alanine Expected value 50"0 75"0 100"0 N 33
Mean 44"9 73"6 95"9 Mean 45"8
CV 2"9 "9 2"0 CV 4"8
Pyruvate Expected value 12"5 25"0 75"0 N 62
Mean 13"6 23"8 72"7 Mean 13"5
CV 8"8 5"7 5"6 CV 15"0
26 2O
128"9 501"5
4"6 4"3
44 18
74"5 98"4
1"7 2"7
36 2O
25"1 51"3
2"7 1"3
35 2O
74"O 97"2
3"3 2"2
3O 2O
24"3 73’4
7"0 6"3
Table 3. Correlation data of methods on COBAS FARA and manual methods in 50 samples (gmol/1).
Mean Mean
lower upper
R Sxy Slope C.I. Interpret case case
Range Range
(min) (max)
Lactate 0"99 75"2 0"98 0"93-1"03 17"9 747 752
//-oh-but 0"99 19"8 0’98 0"94-1’02 14"2 127 138
Alanine 0"98 32"3 1"02 0"94-1" 10 9’4 341 359
Pyruvate 0"99 4"2 0"96 0"90-1"02 2"9 96 95
Glycerol 0"90 17"5 1"03 0"82-1"24 0"44 66 69
150 2390
26 1000
61 577
50 171
23 2OO
X COBAS FARA.
Y-- Spectrophotometric methods.
C.I. Confidence interval.
also more precise (the between-run CV was 4"0 at
24"4 gmol/1 compared with 10 at 44"0 gmol/1 using the
method of Hansen and Freier for fl-hydroxybutyrate).
The high sensitivity ofthe methods is illustrated by the fact
that the reaction sample volumes usually varied from 5
to 10 gl ofPCA precipitates with an even smaller volume
of blood.
Continuous flow methods [15] were also used for the
determination of the intermediate metabolites, but these
methods presented some disadvantages when compared
to fast centrifugal analyser: for example, the need to run
’blank fluorescence’ and to draw calibration graphs and
compare large numbers ofpeaks which can generate gross
errors [16]. The present methods on COBAS FARA II
are similar to a few spectrophotometric or fluorimetric
methods adapted for previous fast centrifugal analysers
[16, 19]. Major innovations are in the ability to create
new reaction modes with mathematical modeling of the
data and particular care in the handling of samples. In
conclusion, the fluorimetric assays for the determination
of intermediate metabolites on COBAS FARA II have a
good sensitivity and precision, are less costly than manual
methods and can be used on a routine basis.
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